Skip to main content

Table 1 Primer Sequences

From: E2F2(E2F transcription factor 2) as a potential therapeutic target in meibomian gland carcinoma: evidence from functional and epigenetic studies

Gene Name

Forward(5′➝3′)

Reverse(5′➝3′)

ESM1

ACCTTCGGGATGGATTGCAG

CCGGGATCAGCGTGGATTTA

OPCML

GGGTTCACCTAATAGTGCAAGTT

CATCCTCACTTACAAAGCCCTG

E2F2

CTGAAGGAGCTGATGAACACG

CCCTTGGGTGCTCTTGAGATA

FAM111B

GCCCTTGAAATGCAGAATCCA

GCTGTAAACACACTACGGTCTAA

MCM10

CCCCTACAGACGATTTCTCGG

CAGATGGGTTGAGTCGTTTCC

CLSPN

TGGAGAGTGGGGTCCATTCAT

CCGGGGTTTACGTTTGAAGAAA

MT2A

CCCGCTCCCAGATGTAAAGA

ATAGCAAACGGTCACGGTCAG

CDC45

CTTGAAGTTCCCGCCTATGAAG

GCATGGTTTGCTCCACTATCTC

CDC6

CCAGGCACAGGCTACAATCAG

AACAGGTTACGGTTTGGACATT

EXO1

TGAGGAAGTATAAAGGGCAGGT

TGTGATATTGATAGACCGGGTGA

E-cadherin

TGGACCGAGAGAGTTTCCCT

CAAAATCCAAGCCCGTGGTG

BAX

CCCGAGAGGTCTTTTTCCGAG

CCAGCCCATGATGGTTCTGAT

CASPASE3

AGAGGGGATCGTTGTAGAAGTC

ACAGTCCAGTTCTGTACCACG

P16

GCCCAACGCACCGAATAGTT

ATGGTTACTGCCTCTGGTGC

P21

TGCCGAAGTCAGTTCCTTGT

CATTAGCGCATCACAGTCGC

P27

TCGGACAGTGATCCACCCTA

GGTTCCCTTCGCCAATCACT

CDK4

GTCTATGGTCGGGCCCTCT

CCATAGGCACCGACACCAAT

GAPDH

GATGCTGGCGCTGAGTACG

GCTAAGCAGTTGGTGGTGC